Robert Blaustein - Chief Development Officer at Edgewise Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Robert Blaustein since 09 Oct 2025

Reported holdings for Robert Blaustein in Edgewise Therapeutics, Inc.

Form 4 holding Chief Development Officer

Edgewise Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
17,500
Estimated value
$821,241
Report date
12 Aug 2025
Price
$27.37
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Robert Blaustein in Edgewise Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .